Approval · Notice of Compliance 19769 · 2017
METFORMIN: Notice of Compliance 19769
Issued September 7, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19769
- Date
- September 7, 2017
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Update to product monograph to be in line with crp
- Canadian reference product
- GLUCOPHAGE (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METFORMIN | Not yet assigned | — |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- METFORMIN HYDROCHLORIDE 850 MG per TAB